The increased abundance of the CD5 antigen‐like apoptosis inhibitor in the disease group may suggest an aggravation of local inflammation, as this protein is associated with diagnostic and prognostic markers in various cancer‐related clinical scenarios (Choi et al. 2021; Okanoue et al. 2022; Yamazaki et al. 2014). The gene discussed is CD5; the disease is cancer.